Huidi Liu

No. 157, Baojian Road
Harbin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Enterolactone mitigates atherosclerosis by facilitating resolution of ferroptosis-associated intimal inflammation via the Keap1/Nrf2/GPX4 pathway.

Enterolactone mitigates atherosclerosis by facilitating resolution of ferroptosis-associated intimal inflammation via the Keap1/Nrf2/GPX4 pathway.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: November 09, 2025

Mupirocin-Piperine Microemulsion Hydrogels Accelerate Healing of Infected Wounds through Deep Penetration and Biofilm Disruption.

Mupirocin-Piperine Microemulsion Hydrogels Accelerate Healing of Infected Wounds through Deep Penetration and Biofilm Disruption.

Journal: Molecular pharmaceutics

Published: June 10, 2025

Enterolactone and THBS1-3TSR synergistically inhibit ovarian cancer and suppress angiogenesis in the tumour microenvironment.

Enterolactone and THBS1-3TSR synergistically inhibit ovarian cancer and suppress angiogenesis in the tumour microenvironment.

Journal: British journal of pharmacology

Published: January 27, 2025

The combination of flaxseed lignans and PD-1/ PD-L1 inhibitor inhibits breast cancer growth via modulating gut microbiome and host immunity.

The combination of flaxseed lignans and PD-1/ PD-L1 inhibitor inhibits breast cancer growth via modulating gut microbiome and host immunity.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: December 29, 2024

Multi-level inhibition of SARS-CoV-2 invasion by cannabidiol and epigallocatechin gallate.

Multi-level inhibition of SARS-CoV-2 invasion by cannabidiol and epigallocatechin gallate.

Journal: Virology

Published: December 14, 2024

Enterolactone promotes efficacy of gemcitabine on epithelial ovarian cancer and ameliorates gut dysbacteriosis.

Enterolactone promotes efficacy of gemcitabine on epithelial ovarian cancer and ameliorates gut dysbacteriosis.

Journal: British journal of pharmacology

Published: November 15, 2024

Mechanisms and benefits of phytochemicals as an alternative therapeutic strategy in female cancers.

Mechanisms and benefits of phytochemicals as an alternative therapeutic strategy in female cancers.

Journal: Chinese herbal medicines

Published: August 08, 2024

Enterolactone combined with m6A Reader IGF2BP3 inhibits malignant angiogenesis and disease progression in ovarian cancer.

Enterolactone combined with m6A Reader IGF2BP3 inhibits malignant angiogenesis and disease progression in ovarian cancer.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: May 30, 2024

Cannabidiol Inhibits Epithelial Ovarian Cancer: Role of Gut Microbiome.

Cannabidiol Inhibits Epithelial Ovarian Cancer: Role of Gut Microbiome.

Journal: Journal of natural products

Published: April 11, 2024

Combined Use of Immune Checkpoint Inhibitors and Phytochemicals as a Novel Therapeutic Strategy against Cancer.

Combined Use of Immune Checkpoint Inhibitors and Phytochemicals as a Novel Therapeutic Strategy against Cancer.

Journal: Journal of Cancer

Published: May 08, 2023

Enterolactone and trabectedin suppress epithelial ovarian cancer synergistically via upregulating THBS1.

Enterolactone and trabectedin suppress epithelial ovarian cancer synergistically via upregulating THBS1.

Journal: Phytotherapy research : PTR

Published: April 15, 2023

Fusobacterium nucleatum upregulates MMP7 to promote metastasis-related characteristics of colorectal cancer cell via activating MAPK(JNK)-AP1 axis.

Fusobacterium nucleatum upregulates MMP7 to promote metastasis-related characteristics of colorectal cancer cell via activating MAPK(JNK)-AP1 axis.

Journal: Journal of translational medicine

Published: February 26, 2023

Showing 1-12 of 31

Last Updated: 09/26/2026